Reinhart Partners Inc. reduced its position in shares of Ventas, Inc. (NYSE:VTR) by 45.0% during the fourth quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 276,664 shares of the real estate investment trust’s stock after selling 226,080 shares during the quarter. Ventas comprises about 1.7% of Reinhart Partners Inc.’s portfolio, making the stock its 29th biggest position. Reinhart Partners Inc. owned approximately 0.08% of Ventas worth $16,210,000 at the end of the most recent reporting period.
A number of other hedge funds have also recently bought and sold shares of VTR. Quadrant Capital Group LLC grew its holdings in Ventas by 30.7% during the fourth quarter. Quadrant Capital Group LLC now owns 1,813 shares of the real estate investment trust’s stock valued at $95,000 after purchasing an additional 426 shares during the period. Columbia Asset Management purchased a new stake in shares of Ventas in the third quarter worth $111,000. Bogart Wealth LLC raised its position in shares of Ventas by 24.3% in the fourth quarter. Bogart Wealth LLC now owns 2,376 shares of the real estate investment trust’s stock worth $139,000 after buying an additional 464 shares in the last quarter. Girard Partners LTD. purchased a new stake in shares of Ventas in the third quarter worth $161,000. Finally, WESPAC Advisors LLC purchased a new stake in shares of Ventas in the third quarter worth $202,000. 85.11% of the stock is currently owned by institutional investors and hedge funds.
In other Ventas news, EVP T Richard Riney sold 15,676 shares of the firm’s stock in a transaction dated Thursday, December 6th. The stock was sold at an average price of $65.00, for a total transaction of $1,018,940.00. The transaction was disclosed in a filing with the SEC, which is accessible through this hyperlink. Company insiders own 1.40% of the company’s stock.
NYSE VTR opened at $61.04 on Tuesday. Ventas, Inc. has a twelve month low of $46.55 and a twelve month high of $65.70. The company has a current ratio of 0.56, a quick ratio of 0.56 and a debt-to-equity ratio of 1.00. The stock has a market cap of $21.76 billion, a price-to-earnings ratio of 14.67, a PEG ratio of 4.69 and a beta of 0.17.
Ventas (NYSE:VTR) last released its quarterly earnings results on Friday, October 26th. The real estate investment trust reported $0.99 earnings per share for the quarter, beating the Zacks’ consensus estimate of $0.97 by $0.02. Ventas had a return on equity of 4.56% and a net margin of 19.90%. The business had revenue of $936.54 million for the quarter, compared to the consensus estimate of $920.19 million. During the same quarter last year, the business posted $1.71 earnings per share. The company’s revenue for the quarter was up 4.1% on a year-over-year basis. On average, analysts predict that Ventas, Inc. will post 4.06 EPS for the current fiscal year.
The company also recently declared a quarterly dividend, which was paid on Monday, January 14th. Shareholders of record on Wednesday, January 2nd were given a dividend of $0.7925 per share. This is an increase from Ventas’s previous quarterly dividend of $0.79. The ex-dividend date of this dividend was Monday, December 31st. This represents a $3.17 dividend on an annualized basis and a yield of 5.19%. Ventas’s dividend payout ratio (DPR) is presently 76.20%.
ILLEGAL ACTIVITY NOTICE: This news story was originally published by Community Financial News and is the property of of Community Financial News. If you are reading this news story on another site, it was illegally copied and republished in violation of United States and international copyright legislation. The correct version of this news story can be viewed at https://www.com-unik.info/2019/01/22/reinhart-partners-inc-reduces-position-in-ventas-inc-vtr.html.
Ventas Company Profile
Ventas, Inc, an S&P 500 company, is a leading real estate investment trust. Its diverse portfolio of approximately 1,200 assets in the United States, Canada and the United Kingdom consists of seniors housing communities, medical office buildings, life science and innovation centers, inpatient rehabilitation and long-term acute care facilities, health systems and skilled nursing facilities.
Further Reading: Compound Interest and Why It Matters When Investing
Want to see what other hedge funds are holding VTR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Ventas, Inc. (NYSE:VTR).
Receive News & Ratings for Ventas Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ventas and related companies with MarketBeat.com's FREE daily email newsletter.